Immune responses to adenovirus and adeno-associated virus in humans
- 1 September 1999
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 6 (9) , 1574-1583
- https://doi.org/10.1038/sj.gt.3300994
Abstract
Vectors based on human adenovirus (Ad) and adeno-associated virus (AAV) are being evaluated for human gene therapy. The response of the host to the vector, in terms of antigen-specific immunity, will play a substantial role in clinical outcome. We have surveyed cohorts of normal subjects and cystic fibrosis patients for pre-existing immunity to these viruses, caused by naturally acquired infections. A number of humoral and cellular assays to adenovirus serotype 5 (Ad5) and adeno-associated virus serotype 2 (AAV2) were performed from serum and peripheral blood mononuclear cells. Virtually all subjects had Ig to Ad5 although only 55% of these antibodies neutralized virus (NAB). Approximately two of three patients demonstrated CD4+ T cells that proliferated to Ad antigens of which most were of the TH1 subset, based on cytokine secretion. A substantially different pattern of immune responses was observed to AAV2. Although virtually all patients had Ig to AAV2, most of these antibodies were not neutralizing (32% NAB) and only 5% of patients had peripheral blood lymphocytes that proliferated in response to AAV2 antigens. These studies demonstrate marked heterogeneity in pre-existing immunity to Ad5 and AAV2 in human populations. The impact of these findings on outcome following gene therapy will require further study.Keywords
This publication has 32 references indexed in Scilit:
- Impact of Preexisting and Induced Humoral and Cellular Immune Responses in an Adenovirus-Based Gene Therapy Phase I Clinical Trial for Localized MesotheliomaHuman Gene Therapy, 1998
- Functional diversity of helper T lymphocytesNature, 1996
- NIDDK Workshop on AAV Vectors: Gene Transfer into Quiescent CellsHuman Gene Therapy, 1996
- Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.Journal of Clinical Investigation, 1996
- Gene therapy for cystic fibrosis: challenges and future directions.Journal of Clinical Investigation, 1995
- Characterization of Human Proliferative T Cell Responses to AdenovirusThe Journal of Infectious Diseases, 1995
- Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosisNature Genetics, 1994
- In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epitheliumCell, 1992
- Simultaneous Administration of Live, Enteric-Coated Adenovirus Types 4,7, and 21 Vaccines: Safety and ImmunogenicityThe Journal of Infectious Diseases, 1979
- Adenovirus-Associated Defective Virus ParticlesScience, 1965